Patents by Inventor Karla K. Kopec

Karla K. Kopec has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES AND USES THEREOF
    Publication number: 20240116995
    Abstract: The present invention relates to a mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate comprising a PEG moiety attached to a mutant FGF-21 peptide via a glycosyl linker and uses thereof. Further provided is a method for producing the mutant FGF-21 peptide conjugate and a pharmaceutical composition and container comprising said mutant FGF-21 peptide conjugate.
    Type: Application
    Filed: May 31, 2023
    Publication date: April 11, 2024
    Applicant: 89BIO LTD.
    Inventors: Karla K. KOPEC, Patrick Mengyuan LIU
  • MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES AND USES THEREOF
    Publication number: 20210355183
    Abstract: The present invention relates to a mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate comprising a PEG moiety attached to a mutant FGF-21 peptide via a glycosyl linker and uses thereof. Further provided is a method for producing the mutant FGF-21 peptide conjugate and a pharmaceutical composition and container comprising said mutant FGF-21 peptide conjugate.
    Type: Application
    Filed: May 27, 2021
    Publication date: November 18, 2021
    Inventors: Karla K. Kopec, Patrick Mengyuan Liu
  • MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES AND USES THEREOF
    Publication number: 20190389921
    Abstract: The present invention relates to a mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate comprising a PEG moiety attached to a mutant FGF-21 peptide via a glycosyl linker and uses thereof. Further provided is a method for producing the mutant FGF-21 peptide conjugate and a pharmaceutical composition and container comprising said mutant FGF-21 peptide conjugate.
    Type: Application
    Filed: July 18, 2019
    Publication date: December 26, 2019
    Inventors: Karla K. KOPEC, Patrick Mengyuan LIU
  • Mutant FGF-21 peptide pegylated conjugates and uses thereof
    Patent number: 10407479
    Abstract: The present invention relates to a mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate comprising a PEG moiety attached to a mutant FGF-21 peptide via a glycosyl linker and uses thereof. Further provided is a method for producing the mutant FGF-21 peptide conjugate and a pharmaceutical composition and container comprising said mutant FGF-21 peptide conjugate.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: September 10, 2019
    Assignee: 89bio Ltd.
    Inventors: Karla K. Kopec, Patrick Mengyuan Liu
  • MUTANT FGF-21 PEPTIDE CONJUGATES AND USES THEREOF
    Publication number: 20190185533
    Abstract: The present invention relates to a mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate comprising a PEG moiety attached to a mutant FGF-21 peptide via a glycosyl linker and uses thereof. Further provided is a method for producing the mutant FGF-21 peptide conjugate and a pharmaceutical composition and container comprising said mutant FGF-21 peptide conjugate.
    Type: Application
    Filed: December 19, 2018
    Publication date: June 20, 2019
    Inventors: Karla K. Kopec, Patrick Mengyuan Liu